Cannabidiol-based treatment receives marketing approval from EMA
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
List view / Grid view
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
Scientists have developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease...